Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Accelerated Phase × Topotecan × 1 year × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 13 Ovarian Neoplasms 12 Neuroblastoma 10 Fallopian Tube Neoplasms 8 Neoplasms 5 Uterine Cervical Neoplasms 4 Ganglioneuroblastoma 4 Carcinoma, Ovarian Epithelial 4 Brain Neoplasms 4 Retinoblastoma 3 Sarcoma, Ewing 2 Recurrence 2 Medulloblastoma 2 Leukemia, Myeloid, Acute 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Thrombocythemia, Essential 1 SCLC, Extensive Stage 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinal Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleuropulmonary blastoma 1 Pediatric Brain Tumor 1 Osteosarcoma 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Meningioma 1

Interventions

Cyclophosphamide 8 fludarabine phosphate 5 Methotrexate 5 ponatinib 4 Whole-Body Irradiation 4 merphos 3 Tacrolimus 3 Rituximab 3 Peripheral Blood Stem Cell Transplantation 3 Mycophenolic Acid 3 CT-P10 3 Busulfan 3 letermovir 2 Vincristine 2 Melphalan 2 Cytarabine 2 Cyclosporine 2 venetoclax 1 prednylidene 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 deltacortene 1 bosutinib 1 blinatumomab 1 auricularum 1 Vorinostat 1 Valganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡